2-Undecylenic Acid

2-Undecylenic Acid

SCHEMBL1268942

CCCCCCC(CCC)C(N)(CCC)CCC.CCCCCCCCC=CC(=O)O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.45
PPARG P37231 4/20 0.40
PPARA Q07869 4/20 0.40
FFAR1 O14842 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39
TERT O14746 3/20 0.39
CYP1A2 P05177 2/20 0.39
MAPT P10636 2/20 0.39
CYP2C19 P33261 2/20 0.39
BLM P54132 2/20 0.39
HSD17B10 Q99714 2/20 0.39
FABP4 P15090 2/20 0.39
FAAH O00519 2/20 0.39
KMT2A Q03164 2/20 0.39
PPARD Q03181 2/20 0.39
GMNN O75496 1/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Undecylenic Acid SCHEMBL1268149 0.97 PTPN1 (0.45) PTPN1PPARGPPARATERTCYP1A2
2-Undecylenic Acid SCHEMBL1267915 0.93 PTPN1 (0.46) PTPN1PPARGPPARATERTCYP1A2
2-Undecylenic Acid SCHEMBL1268951 0.91 PTPN1 (0.46) PTPN1PPARGPPARAFFAR1FFAR4
2-Undecylenic Acid SCHEMBL1268857 0.89 PTPN1 (0.47) PTPN1PPARGPPARATERTCYP1A2
2-Undecylenic Acid SCHEMBL1268957 0.85 PTPN1 (0.48) PTPN1PPARGPPARAFFAR1FFAR4
SCHEMBL11897498 0.80 FDPS (0.40) CYP1A2MAPTBLMGMNNLMNA
SCHEMBL15264996 0.80 FDPS (0.40) CYP1A2MAPTBLMGMNNLMNA
SCHEMBL1010519 0.80 FDPS (0.40) CYP1A2MAPTBLMGMNNLMNA
SCHEMBL11897234 0.80 FDPS (0.40) CYP1A2MAPTBLMGMNNLMNA
Hydrochloric Acid SCHEMBL5088528 0.78 FDPS (0.39) CYP1A2MAPTBLMGMNNLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7880024-B2 Ionic liquids miscible with various polar/non-polar solvents and method of preparing the same SAMSUNG ENGINEERING CO., LTD. (KR) 2011-02-01 US claimed
US-20090253924-A1 Ionic liquids miscible with various polar/non-polar solvents and method of preparing the same SAMSUNG ENGINEERING CO., LTD. (KR) 2009-10-08 US claimed
US-7880024-B2 Ionic liquids miscible with various polar/non-polar solvents and method of preparing the same SAMSUNG ENGINEERING CO., LTD. (KR) 2011-02-01 US disclosed
US-20090253924-A1 Ionic liquids miscible with various polar/non-polar solvents and method of preparing the same SAMSUNG ENGINEERING CO., LTD. (KR) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253924-A1 Ionic liquids miscible with various polar/non-polar solvents and method of preparing the same PIP5K1B, PIP4K2B, PIP4K2C PTPN1 1373/4885PPARG 444/4885PPARA 983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.